In contrast, downregulation of KRT19 has been reported in tumor breast tissue compared to adjacent tissue, and it has been associated with an aggressive phenotype and chemoresistance of cancer cells (Ju et al., 2013; Saha et al., 2017; Saha et al., 2018). This evidence concerns the gene KRT19 and neoplasm.